143 related articles for article (PubMed ID: 35770511)
1. High dose rate brachytherapy in nonmelanoma skin cancer-Systematic review.
Krzysztofiak T; Kamińska-Winciorek G; Pilśniak A; Wojcieszek P
Dermatol Ther; 2022 Sep; 35(9):e15675. PubMed ID: 35770511
[TBL] [Abstract][Full Text] [Related]
2. Skin CanceR Brachytherapy vs External beam radiation therapy (SCRiBE) meta-analysis.
Zaorsky NG; Lee CT; Zhang E; Galloway TJ
Radiother Oncol; 2018 Mar; 126(3):386-393. PubMed ID: 29370985
[TBL] [Abstract][Full Text] [Related]
3. Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients.
Lee CT; Lehrer EJ; Aphale A; Lango M; Galloway TJ; Zaorsky NG
Cancer; 2019 Oct; 125(20):3582-3594. PubMed ID: 31355928
[TBL] [Abstract][Full Text] [Related]
4. The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review.
Alam M; Nanda S; Mittal BB; Kim NA; Yoo S
J Am Acad Dermatol; 2011 Aug; 65(2):377-388. PubMed ID: 21496952
[TBL] [Abstract][Full Text] [Related]
5. Non-melanoma skin cancer treated with high-dose-rate brachytherapy: a review of literature.
Delishaj D; Rembielak A; Manfredi B; Ursino S; Pasqualetti F; Laliscia C; Orlandi F; Morganti R; Fabrini MG; Paiar F
J Contemp Brachytherapy; 2016 Dec; 8(6):533-540. PubMed ID: 28115960
[TBL] [Abstract][Full Text] [Related]
6. Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer.
Paravati AJ; Hawkins PG; Martin AN; Mansy G; Rahn DA; Advani SJ; Hoisak J; Dragojevic I; Martin PJ; Miller CJ; Sanghvi P
Pract Radiat Oncol; 2015; 5(6):e659-64. PubMed ID: 26432680
[TBL] [Abstract][Full Text] [Related]
7. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
[TBL] [Abstract][Full Text] [Related]
8. Aspects of dosimetry and clinical practice of skin brachytherapy: The American Brachytherapy Society working group report.
Ouhib Z; Kasper M; Perez Calatayud J; Rodriguez S; Bhatnagar A; Pai S; Strasswimmer J
Brachytherapy; 2015; 14(6):840-58. PubMed ID: 26319367
[TBL] [Abstract][Full Text] [Related]
9. 3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma.
Ren Y; Zhao Q; Liu H; Huang Y; Wang Z; Cao X; Teh BS; Wen B
BMC Cancer; 2014 Nov; 14():894. PubMed ID: 25432818
[TBL] [Abstract][Full Text] [Related]
10. Interstitial high-dose-rate brachytherapy in eyelid cancer.
Mareco V; Bujor L; Abrunhosa-Branquinho AN; Ferreira MR; Ribeiro T; Vasconcelos AL; Ferreira CR; Jorge M
Brachytherapy; 2015; 14(4):554-64. PubMed ID: 25959364
[TBL] [Abstract][Full Text] [Related]
11. Review: the reemergence of brachytherapy as treatment for non-melanoma skin cancer.
Ota K; Adar T; Dover L; Khachemoune A
J Dermatolog Treat; 2018 Mar; 29(2):170-175. PubMed ID: 28604229
[TBL] [Abstract][Full Text] [Related]
12. From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications.
Guinot JL; Arribas L; Tortajada MI; Crispín V; Carrascosa M; Santos M; Mut A; Vendrell JB; Pesudo C; Chust ML
Brachytherapy; 2013; 12(6):528-34. PubMed ID: 23850275
[TBL] [Abstract][Full Text] [Related]
13. Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort.
Wedde TB; Småstuen MC; Brabrand S; Fosså SD; Kaasa S; Tafjord G; Russnes KM; Hellebust TP; Lilleby W
Radiother Oncol; 2019 Mar; 132():211-217. PubMed ID: 30389241
[TBL] [Abstract][Full Text] [Related]
14. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition.
Pellizzon AC; Salvajoli J; Novaes P; Maia M; Fogaroli R; Gides D; Horriot R
Int J Med Sci; 2008 Jun; 5(3):113-20. PubMed ID: 18566673
[TBL] [Abstract][Full Text] [Related]
16. Second primary malignancies after radiotherapy including HDR (252)Cf brachytherapy for cervical cancer.
Samerdokiene V; Valuckas KP; Janulionis E; Atkocius V; Rivard MJ
Brachytherapy; 2015; 14(6):898-904. PubMed ID: 26194049
[TBL] [Abstract][Full Text] [Related]
17. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy.
Henríquez López I; González-San Segundo C; Vegas JO; Gutierrez C; Hervas A; Cabeza Rodriguez MÁ; Valero Albarrán J; Rodríguez Villalba S; Álvarez Gonzalez A; Sancho Pardo G; Zapatero A; Álvaro PC
Radiother Oncol; 2019 Dec; 141():156-163. PubMed ID: 31570236
[TBL] [Abstract][Full Text] [Related]
18. American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.
Mayadev J; Viswanathan A; Liu Y; Li CS; Albuquerque K; Damato AL; Beriwal S; Erickson B
Brachytherapy; 2017; 16(1):22-43. PubMed ID: 28109631
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
Arenas M; Arguís M; Díez-Presa L; Henríquez I; Murcia-Mejía M; Gascón M; Gómez D; Lafuerza A; Mur E; Azón A; Rovirosa À; Sabater S
Brachytherapy; 2015; 14(6):859-65. PubMed ID: 26489922
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
Yamazaki H; Masui K; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Kotsuma T; Tanaka E; Otani K; Yoshioka Y; Ogawa K
Radiother Oncol; 2019 Mar; 132():162-170. PubMed ID: 30416045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
